Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative

Alireza Ghoreifi1, Anirban P Mitra2, George McClintock3

  • 1Institute of Urology, University of Southern California, Los Angeles, CA.

Urologic Oncology
|November 27, 2022
PubMed
Summary

Robotic retroperitoneal lymph node dissection for testicular cancer is safe and effective, with low complication rates and good oncological outcomes. Further follow-up is needed to confirm long-term results.

Related Concept Videos